Ampio Pharmaceuticals, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q2 2018 to Q4 2023

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Ampio Pharmaceuticals, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q2 2018 to Q4 2023.
  • Ampio Pharmaceuticals, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending December 31, 2023 was 810K shares, a 7.5% increase year-over-year.
  • Ampio Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 810K shares, a 7.5% increase from 2022.
  • Ampio Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 754K shares, a 94.3% decline from 2021.
  • Ampio Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 13.3M shares, a 92.3% decline from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2023 810K +56.5K +7.5% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-27
Q3 2023 804K +50.5K +6.71% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 15.1M +21.6K +0.14% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-08
Q1 2023 15.1M +21.7K +0.14% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-08
Q4 2022 754K -12.5M -94.3% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-27
Q3 2022 754K -12.6M -94.4% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 15.1M -181M -92.3% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 15.1M -180M -92.3% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-08
Q4 2021 13.3M -160M -92.3% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-27
Q3 2021 13.4M -165M -92.5% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 196M +29.8M +17.9% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 195M +36.3M +22.8% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 173M +42.2M +32.3% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-29
Q3 2020 179M +36.4M +25.6% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 166M +51.4M +44.7% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-04
Q1 2020 159M +47.9M +43.2% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q4 2019 131M Oct 1, 2019 Dec 31, 2019 10-K 2021-03-03
Q3 2019 142M +45.3M +46.7% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-03
Q2 2019 115M +28.7M +33.3% Apr 1, 2019 Jun 30, 2019 10-Q 2020-07-31
Q1 2019 111M Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-06
Q3 2018 96.9M Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 86.3M Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.